CN Stock MarketDetailed Quotes

Lionco Pharmaceutical Group (603669)

Watchlist
  • 4.43
  • -0.05-1.12%
Market Closed May 14 15:00 CST
3.16BMarket Cap-18.38P/E (TTM)

Lionco Pharmaceutical Group (603669) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical circulation149.83M46.46%
Cardio-cerebrovascular class91.4M28.34%
Anti-infective class32.94M10.22%
Other business13.61M4.22%
其他药品类13.38M4.15%
Parenteral nutrition13.06M4.05%
Digestive system5.28M1.64%
医院销售及配送2.98M0.92%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry156.06M48.39%
Pharmaceutical circulation149.83M46.46%
Other business13.61M4.22%
医院销售及配送2.98M0.92%
Total special adjustments19--

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China210.36M65.23%
Southwest25.28M7.84%
Central China24.92M7.73%
North China22.49M6.97%
Other business13.61M4.22%
Northwest12.91M4.00%
South China12.51M3.88%
Northeast China402.2K0.12%
Total special adjustments19--
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More